Entero Therapeutics Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Entero Therapeutics has a total shareholder equity of $70.8M and total debt of $177.6K, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are $86.3M and $15.5M respectively.
Belangrijke informatie
0.3%
Verhouding schuld/eigen vermogen
US$177.56k
Schuld
Rente dekkingsratio | n/a |
Contant | US$662.48k |
Aandelen | US$70.80m |
Totaal verplichtingen | US$15.49m |
Totaal activa | US$86.29m |
Recente financiële gezondheidsupdates
Recent updates
First Wave BioPharma announces pricing of $6.0 million public offering
Oct 07First Wave BioPharma extends selloff after announcing strategic shift
Sep 19First Wave stock slips ~21% on plans for amended FDA application for enzyme adrulipase
Sep 07First Wave BioPharma announces 1-for-30 reverse stock split
Aug 25First Wave BioPharma to raise capital in convertible preferred stocks offering
Jul 15First Wave BioPharma Set For New Growth Trajectory With GI Pipeline Expansion De-Risking The Investment
Oct 19AzurRx Biopharma doses first patient in mid-stage niclosamide COVID-19 study
Jun 07AzurRx BioPharma: An Assessment
May 02AzurRx Officially A COVID-19 Play - The Right Dose For Your Portfolio
Jan 31Analyse van de financiële positie
Kortlopende schulden: ENTO's short term assets ($84.4M) exceed its short term liabilities ($15.4M).
Langlopende schulden: ENTO's short term assets ($84.4M) exceed its long term liabilities ($101.0K).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: ENTO has more cash than its total debt.
Schuld verminderen: ENTO's debt to equity ratio has reduced from 64.5% to 0.3% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: ENTO has less than a year of cash runway based on its current free cash flow.
Voorspelling contante baan: ENTO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 11.1% each year